Conditional survival in multiple myeloma and impact of prognostic factors over time
Abstract Overall survival estimates from diagnosis are valuable for guiding treatment, but do not consider the years already survived. Conditional survival (CS) provides dynamic survival predictions over time. This study was conducted to estimate CS at 1–8 years from diagnosis and the impact of base...
Main Authors: | Nadine H. Abdallah, Alexandra N. Smith, Susan Geyer, Moritz Binder, Patricia T. Greipp, Prashant Kapoor, Angela Dispenzieri, Morie A. Gertz, Linda B. Baughn, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, David Dingli, Yi L. Hwa, Yi Lin, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-05-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-023-00852-4 |
Similar Items
-
Mode of progression in smoldering multiple myeloma: a study of 406 patients
by: Nadine H. Abdallah, et al.
Published: (2024-01-01) -
P885: SOLITARY PLASMACYTOMA: SINGLE INSTITUTION EXPERIENCE AND SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL OUTCOMES
by: Charalampos Charalampous, et al.
Published: (2023-08-01) -
Muscle and fat composition in patients with newly diagnosed multiple myeloma
by: Nadine H. Abdallah, et al.
Published: (2023-12-01) -
A simple additive staging system for newly diagnosed multiple myeloma
by: Nadine H. Abdallah, et al.
Published: (2022-01-01) -
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
by: Utkarsh Goel, et al.
Published: (2024-03-01)